![]() |
同义名 : | - |
CAS号 : | 82749-70-0 | |
货号 : | A1176584 | |
分子式 : | C22H28Cl2O4 | |
纯度 : | 99% | |
分子量 : | 427.36 | |
MDL号 : | MFCD07783995 | |
存储条件: |
Pure form Sealed in dry, 2-8°C In solvent -20°C:3-6个月-80°C:12个月 |
|
溶解度 : | - | |
动物实验配方: |
生物活性 | |||
---|---|---|---|
描述 | DCPIB is a selective, reversible and potent inhibitor of VRAC. DCPIB voltage-dependently activates the potassium channels TREK1 and TRAAK, and inhibits TRESK, TASK1, and TASK3 (IC50 values of 0.14, 0.95, and 50.72 μM, respectively). DCPIB is also a selective and swelling-induced blocker of chloride current with an IC50 value of 4.1 μM. DCPIB is an effective tool to study the structure-function of K2P channels. DCPIB at a concentration of 10 μM activates TREK1 and enhances TRAAK currents in COS-7 cells[1][2]. At the same concentration, DCPIB significantly and reversibly inhibited TRESK current in COS-7 cells with an IC50 of 0.14 μM[1]. While acting for 3 hours, DCPIB inhibited LPS-induced MAPK activation in BV2 cells[3]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.34mL 0.47mL 0.23mL |
11.70mL 2.34mL 1.17mL |
23.40mL 4.68mL 2.34mL |